Organ-on-a-Chip Market Revenue to Cross USD 1.1 Billion by 2035 | Roots Analysis

According to the recently published report of Roots Analysis, the growing preferences for research and development activities in the pharmaceutical sector and increasing requirement for non-animal models for drug effects studies are driving the organ-on-a-chip market

Organ on a Chip Market Overview

The global organ-on-a-chip market is anticipated to grow at a CAGR of 21.08% from 2023-2035 reaching USD 1.1 billion by 2035.

The global organ-on-a-chip market growth is likely to be the result of increasing demand for novel drugs to treat diseases and growing preferences for non-animal models to study drug effects. Organ on a chip refers to the microfluidic cell culture with a biosensor-based chip that mimics the organ or organ system of the body. These integrated chips are useful in the evaluation of drug response, such as toxicity and reaction inside the body, in real-time. Owing to its ability to generate real-time data and perform accurate analyses, it has become an essential part of the drug discovery and development process, particularly clinical trials. The trend of using organs on a chip model is increasing because clinical trials on animal models and human volunteers are expensive, time-consuming, and often pose ethical considerations. Moreover, physical models sometimes do not provide accurate predictions as some therapeutic drugs may not show immediate effects on the body. Driven by these factors, several pharmaceutical companies have begun to adopt organ-on-a-chip models for clinical studies. As the demand for these tech-driven devices increases, the organ-on-a-chip market is expected to expand at a substantial rate in the future.

The 218-page report contains a detailed Table of Contents on the "Organ On a Chip Market," Based on the Type of Products, Application Area, Purpose of Origin, and Global Forecasts, 2023-2035" here: https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

Market Drivers

Some of the potential market drivers that are driving the growth in this field include growing research for the development of target-specific therapeutic drugs in the pharmaceutical industry. Additionally, the widespread adoption of organ-on-a-chip devices for clinical studies and the determination of the therapeutic effect of the drugs on humans are key drivers of the market. Moreover, the real-time approach and accurate prediction offered by these organ-on-a-chip (micro-fluid) based models are anticipated to increase the demand for these devices in the future.

Market Restraints

Though the organ chip market is growing at an exponential rate, several factors impede the growth. Some of the potential market restraints that impact its growth are the high initial investment associated with the development of organs on-chip devices. Further, the development of advanced technologies requires meeting stringent regulations that can be challenging for the market players. Despite technological advancements, replicating the human organ model on a chip that accurately mimics the physiological and pathological response can be a significant challenge for key players. Therefore, market players have to mitigate these concerns to achieve steady growth during the forecast period.

Growth Factors

The organ-on-a-chip market is propelled by various growth factors that include growing demand for personalized medicines and advanced technologies that facilitate clinical studies. Further, the increasing adoption of organ-on-a-chip devices across various pharmaceutical industries has become a primary growth factor that drives the market during the forecast period. To meet the growing requirement for novel technologies, several organ-on-a-chip market players have accelerated their research for the development of next-generation devices for real-time drug studies during clinical studies.

Organ on a Chip Market Segments

Based on the Type of Products, Organ on Chip Market is segmented Into a Multi-Organ / Organ-Based Model and a Disease / therapeutic-based model.

• On the basis of the type of products, the multi-organ / organ-based model will dominate the organ-on-a-chip market and is anticipated to capture 76% of the share by 2035.
• Disease / Therapeutic based models have shown significant potential to grow at a higher CAGR of 24% during the forecast period.

Based on the Application Area, Organ On the organ-a-chip market is Segmented Into Cancer Research, Drug Discovery and Toxicity Testing, Stem Cell Research, Tissue Engineering, and Regenerative Medicine.

• On the basis of application area, drug discovery and toxicity testing will dominate the organ-on-a-chip market, capturing 55% of the market share by 2035.
• Tissue engineering and regenerative medicine are projected to grow at a higher compounded annual growth rate (CAGR) of 23% during the forecast period.

Based on the Purpose, the Organ a Chip Market is segmented Into Research and Therapy Development.

• On the basis of purpose, the organ-on-a-chip market is dominated by research and is poised to capture 58% of the revenue share by 2035.
• Therapy development shows higher growth potential during the forecast period and is poised to grow at a higher CAGR of 24% during the forecast period. 

Based on the Geographical Region, the Organ on a Chip Market is Segmented into North America, Europe, Asia-Pacific, and Rest of the World

• Based on the geographical region, North America will dominate the organ-on-a-chip market and is anticipated to hold 47% of the overall revenue share by 2035.
• In the rest of the world, the market is poised to expand at a higher CAGR of 26% from 2023-2035.

Key Companies Profiled

The organ-on-a-chip market report also includes a list of key players actively delivering organ-on-a-chip devices.

• Bianchi
• Dynamic42
• Emulate
• Mimetas
• SynVivo
• TissUse
• uFluidix

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html

About Roots Analysis

Roots Analysis is a specialist market research, competitive intelligence and consulting company, sharing fresh and independent perspectives for the industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact US
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com